Aim of the [Merck-Afrigen Biologics] collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization Merck, a leading science and technology company, announced that its Life Science...

Agency holds off decision on expanding use of shot to 12-to-17-year-olds while it looks into risk of rare heart condition The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s Covid-19 vaccine for...